RESQ PHARMA
Dead / Abandoned — Abandoned — after ex parte appeal (as of 27 Dec 2024)
What this means for you
This application is over — abandoned 27 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97403524
- Mark type
- Stylized text
- Filed
- 10 May 2022
- Abandoned
- 27 Dec 2024
- Attorney of record
- HILLARY E MAYNARD
Goods and services
- Class 042 — Scientific and technological services: Research and development of treatments for Local Anesthetic Systemic Toxicity, Non-Opioid Drug Overdose, and Ischemic Reperfusion Injury
Owner
- ResQ Pharma, Inc., Chicago, IL, US
Prosecution history
- 02 Jan 2025 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 27 Dec 2024 — ABANDONMENT - AFTER EX PARTE APPEAL
- 27 Dec 2024 — EXPARTE APPEAL TERMINATED
- 14 Nov 2024 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 06 May 2024 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 06 May 2024 — ACTION DENYING REQ FOR RECON E-MAILED
- 06 May 2024 — ACTION CONTINUING FINAL - COMPLETED
- 16 Feb 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 16 Feb 2024 — EX PARTE APPEAL-INSTITUTED
- 16 Feb 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 16 Feb 2024 — EXPARTE APPEAL RECEIVED AT TTAB
- 16 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 16 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 21 Aug 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Aug 2023 — FINAL REFUSAL E-MAILED